Welcome to Sapien Biosciences
We are under construction
Please check back later for more updates
Locate Us
Sapien Biosciences,
1st Floor, AIMSR Building,
Apollo Health City,
Jubilee Hills,
Hyderabad 500 096
Phone:
+91-99859 25652
+91-73863 01984
Email:
info@sapienbio.com
queries@sapienbio.com
Recent Comments
- Chinnababu Sunkavalli on The largest category of breast cancers are hormone receptor (HR) positive. These comprise 55-60% of all breast cancers globally as well as in India. Unlike triple negative breast cancer (TNBC), HR positive breast cancers respond well to personalized treatment with newer drugs and have a high chance of successful treatment and long-term survival even in advanced stages. Hence it is important to get them diagnosed and typed for HR positivity early on and tailor the treatment for each patient.
- ashwin shah on The largest category of breast cancers are hormone receptor (HR) positive. These comprise 55-60% of all breast cancers globally as well as in India. Unlike triple negative breast cancer (TNBC), HR positive breast cancers respond well to personalized treatment with newer drugs and have a high chance of successful treatment and long-term survival even in advanced stages. Hence it is important to get them diagnosed and typed for HR positivity early on and tailor the treatment for each patient.
- drchinnababu on Breast Cancer Protection,
Recent Posts
- Dr. Jugnu Jain, CEO, delivering an invited talk on “Sustainability of Biobanking in India” at the workshop on Biobanking organized by ILBS, New Delhi.
- Quatramer’s tunability stems from the fact that the system can be modified and adjusted to deliver single or multiple ratios of payloads in order to optimize synergistic mechanisms of action in lower doses.
- Our paper is out in Frontiers in Pharmacology
- Sapien’s work for Hillstream BioPharma presented at AACR
- Dr. Jugnu Jain shares her thoughts on entrepreneurship with the T-Hub Hyderabad
Leave a Reply
Want to join the discussion?Feel free to contribute!